Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

SELL
$191.17 - $325.63 $863,706 - $1.47 Million
-4,518 Reduced 18.07%
20,486 $6.67 Million
Q4 2023

Feb 06, 2024

SELL
$160.99 - $215.69 $330,673 - $443,027
-2,054 Reduced 7.59%
25,004 $4.77 Million
Q3 2023

Nov 08, 2023

BUY
$194.33 - $283.97 $156,824 - $229,163
807 Added 3.07%
27,058 $5.39 Million
Q2 2023

Aug 11, 2023

BUY
$223.05 - $302.68 $466,843 - $633,509
2,093 Added 8.66%
26,251 $7.49 Million
Q1 2023

May 02, 2023

SELL
$175.41 - $217.92 $223,472 - $277,630
-1,274 Reduced 5.01%
24,158 $5.24 Million
Q4 2022

Feb 10, 2023

BUY
$204.38 - $296.82 $19,211 - $27,901
94 Added 0.37%
25,432 $5.23 Million
Q3 2022

Nov 09, 2022

BUY
$195.21 - $310.53 $197,552 - $314,256
1,012 Added 4.16%
25,338 $7.05 Million
Q2 2022

Aug 15, 2022

BUY
$115.91 - $214.48 $2.18 Million - $4.04 Million
18,846 Added 343.91%
24,326 $4.65 Million
Q1 2022

Jun 30, 2022

SELL
$127.96 - $207.36 $58,733 - $95,178
-459 Reduced 7.73%
5,480 $1.14 Million
Q4 2021

Feb 15, 2022

SELL
$165.13 - $241.83 $10,733 - $15,718
-65 Reduced 1.08%
5,939 $1.06 Million
Q3 2021

Oct 29, 2021

SELL
$163.99 - $235.57 $60,348 - $86,689
-368 Reduced 5.78%
6,004 $1.24 Million
Q2 2021

Aug 16, 2021

BUY
$131.45 - $201.49 $305,095 - $467,658
2,321 Added 57.29%
6,372 $1.21 Million
Q1 2021

May 13, 2021

SELL
$92.73 - $142.05 $36,628 - $56,109
-395 Reduced 8.88%
4,051 $528,000
Q4 2020

Feb 12, 2021

BUY
$67.44 - $103.72 $1,551 - $2,385
23 Added 0.52%
4,446 $461,000
Q3 2020

Oct 30, 2020

BUY
$42.79 - $75.8 $6,846 - $12,128
160 Added 3.75%
4,423 $335,000
Q2 2020

Aug 10, 2020

BUY
$27.25 - $47.53 $116,166 - $202,620
4,263 New
4,263 $202,000
Q1 2020

May 13, 2020

SELL
$23.16 - $47.74 $107,277 - $221,131
-4,632 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$29.4 - $44.98 $136,180 - $208,347
4,632 New
4,632 $203,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.